Tekmira Ebola drug used in American doc, others
This article was originally published in Scrip
Executive Summary
After much speculation, Nebraska doctors at a special biocontainment unit treating an American physician infected with the Ebola virus confirmed on 22 September the experimental drug he received was indeed Tekmira's Pharmaceuticals' RNA interference (RNAi) medicine TKM-Ebola.